IFNA1 and COVID-19: The generation of syncytia provides a possible mechanism for delayed IFN response in COVID-19 patients, indicating that the production of type I IFN is inhibited at early stage of SARS-CoV-2 infection, but then substantially activated at the late stage (44, 53).